Hypomethylation-enhanced CRTC2 expression drives malignant phenotypes and primary resistance to immunotherapy in hepatocellular carcinoma
Article in iScience (June 2024)
The most recent citing publications are shown below. View all 8 publications that cite this research output on Dimensions.
Article in iScience (June 2024)
Article in Journal of Hepatocellular Carcinoma (May 2024)
Article in Journal of the National Cancer Institute (January 2024)